Abstract
Transplantation tolerance has become an experimental reality, yet the bridge from the laboratory to the clinic has only begun to be traversed. Many obstacles remain before patients will be able to benefit from the extraordinary advances in transplant immunology. This paper presents an overview of issues that will likely affect the clinical development of broadly applicable tolerance regimens. Biologic issues as well as issues related to drug development are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
